Testing FLQ-101 in premature newborns
Part of Eyes & vision, Genetic & congenital clinical trials.
This study tests an experimental medicine called FLQ-101 in very premature newborns to see how safe it is and how the body processes it. It may help babies who are born at 26 to 27 weeks of pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby must be born between 26 weeks, 0 days and 27 weeks, 6 days of pregnancy.
- Your baby must weigh at least 650 grams at birth.
- You or the legal guardian must sign a consent form.
- Your baby cannot have serious eye problems, birth defects, severe infections, or heart disease.
- Your baby cannot have had a significant brain bleed (grade 2, 3, or 4).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the tiny blood vessels in the back of the eye (retina) of premature infants who are at risk for retinopathy of prematurity, a condition that can harm vision. It aims to improve care and monitoring by using advanced eye imaging to see more detail than current methods.
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
This study looks at long-term eye health in people who were born prematurely and had retinopathy of prematurity (ROP) screening as babies. It aims to understand how the eyes develop over many years.
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
This trial looks at whether red blood cell transfusions are linked to health problems in very premature babies. It may help doctors better understand how to care for these infants.
This study looks at newborn eye exams and genetic information to better understand why some premature infants develop a serious vision problem called ROP. You may be invited because your baby needs routine eye screening or is being moved for specialized eye care.
Hear when a new Retinopathy of Prematurity (ROP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.